BHC

Bausch Health Companies Inc. (NYSE:BHC) is a multinational pharmaceutical and medical device company headquartered in Laval, Canada. Originally founded as a pharmaceutical company in 1994, the company underwent significant transformation under the name Valeant Pharmaceuticals International through aggressive acquisitions in the 2000s and 2010s. Following a period of financial distress and regulatory scrutiny, the company rebranded to Bausch Health Companies in July 2018 and has since focused on stabilizing its operations and reducing debt. Today, Bausch Health operates as a diversified healthcare company with a portfolio spanning pharmaceuticals, medical devices, and over-the-counter products across multiple therapeutic areas including eye health, gastroenterology, and dermatology.